GALAPAGOS

galapagos-logo

Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines that will improve people's lives.

#SimilarOrganizations #People #Financial #Event #Website #More

GALAPAGOS

Social Links:

Industry:
Biopharma Biotechnology Clinical Trials Health Care Medical

Founded:
1999-01-01

Address:
Mechelen-bovelingen, Limburg, Belgium

Country:
Belgium

Website Url:
http://www.glpg.com

Total Employee:
251+

Status:
Active

Contact:
+32 15 34 29 00

Email Addresses:
[email protected]

Total Funding:
5.45 B USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.


Current Advisors List

onno-stolpe_image

Onno Stolpe Member of Board of Directors @ Galapagos
Board_member
1999-01-01

katrine-bosley_image

Katrine Bosley Board Member @ Galapagos
Board_member
2013-01-01

stephen-bunting_image

Stephen Bunting Board memeber @ Galapagos
Board_member

Current Employees Featured

onno-stolpe_image

Onno Stolpe
Onno Stolpe CEO @ Galapagos
CEO
1999-01-01

werner-cautreels_image

Werner Cautreels
Werner Cautreels Director @ Galapagos
Director

andre-hoekema_image

Andre Hoekema
Andre Hoekema Chief Business Officer @ Galapagos
Chief Business Officer

bart-filius_image

Bart Filius
Bart Filius Chief Operating Officer & Chief Financial Officer @ Galapagos
Chief Operating Officer & Chief Financial Officer

walid-abi-saab_image

Walid Abi-Saab
Walid Abi-Saab Chief Medical Officer @ Galapagos
Chief Medical Officer

piet-wigerinck_image

Piet Wigerinck
Piet Wigerinck Chief Scientific Officer @ Galapagos
Chief Scientific Officer

kruti-popat_image

Kruti Popat
Kruti Popat Director, Customer Insights & Engagement @ Galapagos
Director, Customer Insights & Engagement

paul-passier_image

Paul Passier
Paul Passier Director Clinical Pharmacology @ Galapagos
Director Clinical Pharmacology
2018-01-01

michele-manto_image

Michele Manto
Michele Manto Chief Commercial Officer @ Galapagos
Chief Commercial Officer
2020-01-01

philip-vyt_image

Philip Vyt
Philip Vyt Senior Director Global Omnichannel Capabilities & Digital Innovation @ Galapagos
Senior Director Global Omnichannel Capabilities & Digital Innovation
2020-10-01

Founder


dinko-valerio_image

Dinko Valerio

onno-stolpe_image

Onno Stolpe

rudi-pauwels_image

Rudi Pauwels

Stock Details


Company's stock symbol is VIE:GLPG

Acquisitions List

Date Company Article Price
2022-06-21 CellPoint CellPoint acquired by Galapagos 125 M EUR
2021-06-21 Abound Bio Abound Bio acquired by Galapagos 14 M USD
2013-01-15 Cangenix Cangenix acquired by Galapagos N/A
2010-02-02 Argenta Discovery Argenta Discovery acquired by Galapagos N/A
2007-01-02 ProStrakan ProStrakan acquired by Galapagos 31 M EUR
2006-12-07 Inpharmatica Inpharmatica acquired by Galapagos 19.1 M EUR
2005-09-21 BioFocus DPI BioFocus DPI acquired by Galapagos 36.5 M USD

Investors List

gilead-sciences_image

Gilead Sciences

Gilead Sciences investment in Post-IPO Equity - Galapagos

university-of-antwerp_image

University of Antwerp

University of Antwerp investment in Grant - Galapagos

van-herk-ventures_image

Van Herk Ventures

Van Herk Ventures investment in Post-IPO Equity - Galapagos

the-institute-for-the-promotion-of-innovation-by-science-and-technology-in-flanders_image

The Institute for the Promotion of Innovation by Science and Technology in Flanders

The Institute for the Promotion of Innovation by Science and Technology in Flanders investment in Grant - Galapagos

thuja-capital_image

Thuja Capital

Thuja Capital investment in Venture Round - Galapagos

the-institute-for-the-promotion-of-innovation-by-science-and-technology-in-flanders_image

The Institute for the Promotion of Innovation by Science and Technology in Flanders

The Institute for the Promotion of Innovation by Science and Technology in Flanders investment in Grant - Galapagos

the-institute-for-the-promotion-of-innovation-by-science-and-technology-in-flanders_image

The Institute for the Promotion of Innovation by Science and Technology in Flanders

The Institute for the Promotion of Innovation by Science and Technology in Flanders investment in Grant - Galapagos

gilde-healthcare-partners_image

Gilde Healthcare

Gilde Healthcare investment in Venture Round - Galapagos

Investments List

Date Company Article Money raised
2013-07-01 Vitalnext Galapagos investment in Funding Round - Vitalnext N/A

Key Employee Changes

Date New article
2022-01-26 Galapagos appoints Paul Stoffels as Chief Executive Officer

Official Site Inspections

http://www.glpg.com Semrush global rank: 39.37 K Semrush visits lastest month: 3.28 M

  • Host name: s3-website-eu-west-1.amazonaws.com
  • IP address: 52.92.36.148
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Galapagos"

Organization, structure and operation - Galapagos NV Annual โ€ฆ

Risks related to our organization, structure and operation Continuous required successful attracting and retaining qualified personnel Our future success depends on our ability to retain โ€ฆSee details»

Organization, structure and operation - Galapagos โ€ฆ

Risks related to our organization, structure and operation. Risk factors CSR report. Galapagos NV โ€ข Annual Report 2018. Our future success depends on our ability to retain the members of our executive committee and to attract, retain โ€ฆSee details»

Organization, structure and operation - Galapagos โ€ฆ

Organization, structure and operation. CSR report. Galapagos NV โ€ข Annual Report 2019. Our future success depends on our ability to retain the members of our executive committee and to attract, retain and motivate qualified โ€ฆSee details»

Living Innovation - glpg.com

Indications. We have built an organization based Pioneering for patients Diversifying and accelerating our pipeline Partnering for greater impact Making it happen, together, as a team โ€ฆSee details»

Galapagos announces full year 2023 results and outlook for 2024

Dec 31, 2023 Webcast presentation tomorrow, 23 February 2024, at 14:00 CET / 8:00 am ET, www.glpg.com. Mechelen, Belgium; 22 February 2024, 22:01 CET; regulated information โ€“ โ€ฆSee details»

Galapagos - LinkedIn

Galapagos | 74,808 followers on LinkedIn. We are a biotechnology company with operations in Europe and the U.S. dedicated to developing transformational medicines for more years of life and ...See details»

Board of Directors - Galapagos

Corporate Governance. Our commitment to Corporate Governance. We believe in transparency, accountability, and ethical leadership. To learn more about our corporate governance principles, our board of directors, and our dedication to โ€ฆSee details»

The Global LPG Partnership

The GLPGP Mission: Assist developing countries and their stakeholders to plan, finance and implement the appropriate, evidence-based, national-scale availability and use of LPG โ€ฆSee details»

Organization, structure and operation - Galapagos Annual Report โ€ฆ

Organization, structure and operation. CSR report. Galapagos NV โ€ข Annual Report 2020. Our future success depends on our ability to retain the members of our management board and to โ€ฆSee details»

Galapagos enters into strategic collaboration agreement

Jan 4, 2024 Media inquiries: Marieke Vermeersch +32 479 490 603 [email protected] : Investor inquiries: Sofie Van Gijsel +1 781 296 1143 [email protected] Sandra CauwenberghsSee details»

Our story - Galapagos

June. Galapagos announced the acquisition of CellPoint and AboundBio, propelling Galapagos into next-generation cell therapy while significantly broadening its portfolio and โ€ฆSee details»

What We Do - The Global LPG Partnership

At GLPGP, we: Create national LPG and bio-LPG plans. GLPGP partners with host country governments and other stakeholders to create national plans for rapid, sustainable scale-up of โ€ฆSee details»

Organization, structure and operation - Galapagos NV Annual โ€ฆ

Risks related to our organization, structure and operation Our future success depends on our ability to retain the members of our management board and to attract, retain and motivate โ€ฆSee details»

Executive Committee - Galapagos NV Annual Report 2022

Dec 31, 2022 He joined Galapagos in September 2017 as Senior Vice President Commercial Operations to build and lead Galapagosโ€™ commercial organization and capabilities. Previously, โ€ฆSee details»

Our organization | Who we are | Home - bp

Our organization. bp has three main businesses โ€“ production & operations, gas & low carbon energy and customers & products โ€“ enabled by trading & shipping. Production & operations โ€ฆSee details»

Corporate Governance Charter - glpg.com

Page 2 of 23 Introduction This corporate governance charter (the โ€œCharterโ€) supplements the corporate governance terms set forth in the Code of Companies and Associations and the โ€ฆSee details»

Our Sustainability Governance - Galapagos NV Annual Report 2022

We value our planet and take initiatives to safeguard the environment and incorporate greener practices across our organization Development. All activities required to bring a new drug to โ€ฆSee details»

People - Galapagos

As we actively seek to develop a diverse and inclusive workplace, we aim to define a roadmap to achieve our goal of being a more diverse, equitable and inclusive organization by 2028 and to โ€ฆSee details»

linkstock.net © 2022. All rights reserved